510(k) Report

510(k) · Cleared

Cleared

P200TE (A10700)

K233602510(k) TraditionalCleared May 9, 2024182-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Optos Plc. · OBO Tomography, Optical Coherence

Cleared on May 9, 2024 as substantially equivalent to K121739 (Optovue, Inc., 2013) and 1 other predicate after a 182-day review. Its family tree reaches back 8 generations to 2002.

Decided
May 9, 2024
Review
182 days
Class
Class II
Product code
OBO
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K012727 (2002). 26 ancestors in all, the oldest K871268 (1987). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2018: 1 other ancestor2010: 3 other ancestors2015: 1 other ancestor2008: 1 other ancestor2006: 2 other ancestors2014: 1 other ancestor2005: 2 other ancestors1997: 1 other ancestor1994: 1 other ancestor2004: 1 other ancestor1999: 1 other ancestor1998: 1 other ancestor1989: 1 other ancestor1987: 1 other ancestorK012727 · Humphrey OCT3 · Carl Zeiss Ophthalmic Systems, Inc. · 2002K030433 · Stratusoct with RNFL Normative Database · Carl Zeiss Meditec, Inc. · 2003 · recalledK033123 · Stratusoct with RNFL & Macula Normative Database · Carl Zeiss Meditec, Inc. · 2004 · recalledK063343 · Bioptigen Spectral Domain Ophthalmic Imaging System · Bioptigen, Inc. · 2006K071250 · CA, Model: Cam · Optovue, Inc. · 2007K091404 · Ivue, Model 100 · Optovue, Inc. · 2010 · recalledK121739 · Ivue with Normative Database · Optovue, Inc. · 2013 · recalledK231673 · P200TE (A10700) · Optos Plc. · 20231990200020102020
  1. Root · 8 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 7 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
  3. 6 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
  4. 5 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
  5. 4 generations backK071250 CA, Model: CamOptovue, Inc. · 2007
  6. 3 generations backK091404 Ivue, Model 100Optovue, Inc. · 2010 · Recalled
  7. 2 generations backK121739 Ivue with Normative DatabaseOptovue, Inc. · 2013 · Recalled
  8. 1 generation backK231673 P200TE (A10700)Optos Plc. · 2023
  9. This deviceK233602 P200TE (A10700)Optos Plc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K012727Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc.2002—
−7K030433Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc.20031
−6K033123Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc.20041
−5K063343Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc.2006—
−4K071250CA, Model: CamOptovue, Inc.2007—
−3K091404Ivue, Model 100Optovue, Inc.20102
−2K121739Ivue with Normative DatabaseOptovue, Inc.20133
−1K231673P200TE (A10700)Optos Plc.2023—
0 (this device)K233602P200TE (A10700)Optos Plc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
198910
199410
199710
199810
199910
200410
200520
200620
200810
201030
201410
201510
201810
FIG. 1 — Lineage of K233602, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBO device

  1. #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121739Ivue with Normative Database
Summary page 5
…l Coherence Regulatory Class 886.1570 Product Code OBO, MYC 3. Legally Marketed Predicate Devices Predicate # K121739 (Primary) K231673 Device Trade Name iVue P200TE (A10700) Product Code…
Optovue, Inc.20133
*K231673P200TE (A10700)
Summary page 5
…886.1570 Product Code OBO, MYC 3. Legally Marketed Predicate Devices Predicate # K121739 (Primary) K231673 Device Trade Name iVue P200TE (A10700) Product Code OBO, HLI…
Optos Plc.2023—

Also cleared against K121739: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 5 companies; a new generation was cleared every 2.6 years on median.
  • 5 of the 26 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K121739.

How does its category compare?

All OBO devices

OBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · OBO

3in 2025

2007: 22008: 22009: 42010: 22011: 22012: 32013: 22014: 32015: 12016: 42017: 42018: 62019: 52020: 22021: 12022: 22023: 72024: 82025: 32026 (partial year): 2
2007high 8 (2024) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBO

125in 2025

2009: 151 days median2012: 269 days median2014: 152 days median2016: 125 days median2017: 118 days median2018: 87 days median2019: 249 days median2023: 262 days median2024: 157 days median2025: 125 days median
2007high 269 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBO

1in 2022

2010: 12011: 22012: 22018: 12021: 12022: 12026 (partial year): 1
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBO

4in 2025

2013: 22016: 12018: 12021: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
2009415100
20102—10
20112—20
2012326920
20132—02
2014315200
20151—00
2016412501
2017411800
201868711
2019524900
20202—00
20211—11
20222—10
2023726203
2024815703
2025312504
20262—1—

What is it indicated for?

The P200TE is a non-contact scanning laser ophthalmoscope and optical coherence tomographer. It is intended for in-vivo viewing, digital imaging, and measurement of posterior ocular structures, including the retina, retinal nerve fiber layer, ganglion cell complex (GCC) and optic disc under mydriatic and nonmydriatic conditions. P200TE is indicated for producing high resolution, ultra-widefield, en face reflectance images, autofluorescence images, axial…

Read the full statement (141 words)

The P200TE is a non-contact scanning laser ophthalmoscope and optical coherence tomographer. It is intended for in-vivo viewing, digital imaging, and measurement of posterior ocular structures, including the retina, retinal nerve fiber layer, ganglion cell complex (GCC) and optic disc under mydriatic and nonmydriatic conditions.

P200TE is indicated for producing high resolution, ultra-widefield, en face reflectance images, autofluorescence images, axial cross-sectional images, three-dimensional images, retinal layer boundary analysis, optic nerve head analysis and thickness maps.

The P200TE includes a Reference Database that enables the results of OCT segmentation analysis to be compared to reference data, including Full retinal thickness, Ganglion Cell Complex thickness, Retina Nerve Fiber Layer thickness and Optic Nerve Head metrics.

The P200TE is indicated for use as a device to aid in the detection, diagnosis, documentation and management of retinal health and diseases that manifest in the retina.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K233602: P200TE (A10700).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233602

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026